Jaw1 Activators
Jaw1 activators constitute a group of compounds that interact with various components of the intracellular calcium signaling pathways, such as calcium channels, receptors, and pumps. These activators, which are predominantly modulators of calcium dynamics, exert their influence by changing the concentration of intracellular calcium, which is a critical second messenger in many cellular processes.
Compounds like caffeine, ryanodine, and calcimycin function by directly altering the levels of intracellular calcium, either by blocking the reuptake of calcium into the endoplasmic reticulum or by facilitating its release or entry into the cytoplasm. Such changes in calcium dynamics can indirectly affect Jaw1 by altering the overall context of calcium signaling within the cell. The outcome of such modulation can lead to the activation of Jaw1 due to its role in calcium-dependent cellular processes.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
An antagonist of adenosine receptors that can increase cytosolic calcium levels, thereby influencing the calcium-signaling pathway and indirectly affecting the role of Jaw1 in these pathways. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
An inhibitor of inositol 1,4,5-triphosphate receptors (IP3Rs) that can modulate calcium release from the endoplasmic reticulum, potentially altering the interaction of Jaw1 with IP3Rs and modulating its activity. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
An alkaloid that selectively binds to ryanodine receptors (RyRs) and modulates intracellular calcium levels, which could affect the functional dynamics of Jaw1 by altering calcium fluxes that Jaw1 is associated with. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
An inhibitor of the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) pumps, leading to increased cytosolic calcium concentration. This elevation in calcium can indirectly affect Jaw1 activity, as it may alter calcium-dependent signaling processes. | ||||||
Cyclopiazonic Acid | 18172-33-3 | sc-201510 sc-201510A | 10 mg 50 mg | $176.00 $624.00 | 3 | |
Another SERCA pump inhibitor that can cause an increase in intracellular calcium concentration, thereby influencing the calcium signaling pathways and possibly Jaw1's role in these pathways. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
A cell-permeable calcium chelator that can buffer intracellular calcium levels and thus indirectly influence Jaw1 activity by modifying the calcium signaling environment in which it operates. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
A calcium channel blocker that can reduce calcium influx, indirectly modulating the activity of Jaw1 by altering the calcium signaling landscape within the cell. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
An ionophore that increases intracellular calcium levels by transporting calcium across cell membranes, potentially altering the regulatory role of Jaw1 in calcium signaling. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
A calcium channel blocker that can modulate calcium entry into the cell and thus influence the intracellular signaling pathways involving Jaw1. | ||||||
Carbachol | 51-83-2 | sc-202092 sc-202092A sc-202092C sc-202092D sc-202092B sc-202092E | 1 g 10 g 25 g 50 g 100 g 250 g | $122.00 $281.00 $388.00 $683.00 $1428.00 $3060.00 | 12 | |
A cholinergic agonist that can increase intracellular calcium by stimulating G protein-coupled receptors, potentially influencing the functional context in which Jaw1 operates. | ||||||